Target intelligence / Profile preview

Oxidase (null)

Target
null
Molecular classification
Enzyme, Oxidoreductase family, Flavoprotein-dependent enzymes, Metal cofactor-dependent enzymes, Membrane-bound or soluble forms
01

Overview

Oxidases are a subclass within the broader family of oxidoreductase enzymes, defined by their ability to catalyze oxidation-reduction reactions where molecular oxygen acts as an electron acceptor. This process results either directly in water formation or more commonly produces reactive oxygen species such as hydrogen peroxide. Notable members include NADPH oxidases, which generate superoxide crucial both for host defense mechanisms and pathological processes like cardiovascular remodeling; monoamine oxidases, which metabolize neurotransmitters; and cytochrome c oxidase involved in mitochondrial respiration. Because they regulate redox balance, signal transduction, metabolism, immune response, cell growth/death decisions—and because dysregulation leads directly to diseases including hypertension, cancer, neurodegeneration—they represent important therapeutic targets across multiple medical fields.[1][3][4] However, “oxidases” is not sufficiently precise when referring to drug targets; specificity at least at the gene/protein level is required for actionable biomedical information.

Other names
Oxidoreductase (broader class)NADPH oxidase (NOX)Monoamine oxidase (MAO)Cytochrome c oxidaseEC 1.1–1.99.x.x enzymes
02

Mechanism of action

Drugs targeting these enzymes typically act by: * Inhibiting electron transfer within the catalytic core, thus reducing ROS generation. * Blocking substrate binding sites. * Modulating regulatory subunits or post-translational modifications that control activity.

03

Biological functions

Catalysis of oxidation-reduction reactions by transferring electrons from substrates to oxygen moleculesGeneration of reactive oxygen species (ROS) such as superoxide anion (O2-) and hydrogen peroxide (H2O2)Regulation of cellular signaling pathways via ROS productionMetabolism of neurotransmitters and biogenic amines in the case of monoamine or semicarbazide-sensitive amine oxidases
04

Disease associations

Cardiovascular disease/hypertension/atherosclerosis—especially for NADPH/NADH-dependent vascular cell-associated isoformsCancer—due to chronic oxidative stress promoting DNA damage/cell proliferation/apoptosis evasionNeurodegenerative diseases—monoamine/other brain-expressed isoforms implicated in Parkinson’s/Alzheimer’s disease due to altered neurotransmitter metabolism and oxidative stressInflammation—chronic ROS production drives tissue injury/inflammatory signaling cascades
05

Safety considerations

Off-target effects due to broad expression across tissuesDisruption of physiological ROS signaling required for normal cell function can lead to immunosuppression or impaired wound healing.Potential toxicity from accumulation/depletion of metabolic intermediates
06

Interacting drugs

Setanaxib/GKT137831

2 more in the full profile.

07

Biomarkers

Levels/activity assays for superoxide/hydrogen peroxide productionExpression levels/mutations/polymorphisms in genes encoding individual isoforms like NOX1–NOX5 or MAOA/B

Beyond the preview

Go deeper on Oxidase (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidase (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call